First Trust Advisors
PRVL

First Trust Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

First Trust Advisors’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,571
Closed -$382K – 2502
2020
Q4 		$382K Sell
16,571
-733
-4% -$16.9K ﹤0.01% 2177
2020
Q3 		$176K Buy
+17,304
New +$176K ﹤0.01% 2247